Nanna, Michael G. http://orcid.org/0000-0001-5745-1636
Peterson, Eric D.
Wojdyla, Daniel
Navar, Ann Marie
Funding for this research was provided by:
National Institutes of Health (T-32-HL069749-15, K01HL133416-01)
Article History
Received: 24 July 2019
Revised: 24 July 2019
Accepted: 12 September 2019
First Online: 30 October 2019
Compliance with Ethical Standards
:
: MG Nanna: No relationship(s) to disclose.ED Peterson: Research Grant: Significant; Amgen, Sanofi, Astrazeneca, Merck. Consultant/Advisory Board; Modest; Amgen. Consultant/Advisory Board: Significant; AstraZeneca, Merck, and Sanofi Aventis.D Wojdyla: No relationship(s) to disclose.AM Navar: Research Grant: Significant; Amarin, Janssen, Amgen, Sanofi, and Regeneron Pharmaceuticals. Consultant/Advisory Board: Significant; Amarin, Amgen, Novonordisk, AstraZeneca, Sanofi and Regeneron.
Free to read: This content has been made available to all.